Publications

Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)  (2025)

Authors:
Paolisso, Pasquale; Belmonte, Marta; Gallinoro, Emanuele; Scarsini, Roberto; Bergamaschi, Luca; Portolan, Leonardo; Armillotta, Matteo; Esposito, Giuseppe; Moscarella, Elisabetta; Benfari, Giovanni; Montalto, Claudio; Shumkova, Monika; de Oliveira, Elayne Kelen; Angeli, Francesco; Orzalkiewicz, Mateusz; Fabroni, Margherita; Baydaroglu, Nurcan; Munafò, Andrea Raffaele; D'Atri, Daniele Oreste; Casenghi, Matteo; Scisciola, Lucia; Barbieri, Michelangela; Marfella, Raffaele; Gragnano, Felice; Conte, Edoardo; Pellegrini, Dario; Ielasi, Alfonso; Andreini, Daniele; Penicka, Martin; Oreglia, Jacopo Andrea; Calabrò, Paolo; Bartorelli, Antonio; Pizzi, Carmine; Palmerini, Tullio; Vanderheyden, Marc; Saia, Francesco; Ribichini, Flavio; Barbato, Emanuele
Title:
Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)
Year:
2025
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Referee:
No
Name of journal:
CARDIOVASCULAR DIABETOLOGY
ISSN of journal:
1475-2840
N° Volume:
24
Number or Folder:
1
Page numbers:
1-14
Keyword:
aortic stenosis
Short description of contents:
Background A substantial number of patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) experience adverse events after TAVI, with health care expenditure. We aimed to investigate cardiac remodeling and long-term outcomes in diabetic patients with severe AS, left ventricular ejection fraction (LVEF) < 50%, and extra-valvular cardiac damage (EVCD) undergoing TAVI treated with sodium-glucose cotransporter-2 inhibitors (SGLT2i) versus other glucose-lowering strategies (no-SGLT2i users).
Product ID:
144135
Handle IRIS:
11562/1152787
Last Modified:
January 30, 2025
Bibliographic citation:
Paolisso, Pasquale; Belmonte, Marta; Gallinoro, Emanuele; Scarsini, Roberto; Bergamaschi, Luca; Portolan, Leonardo; Armillotta, Matteo; Esposito, Giuseppe; Moscarella, Elisabetta; Benfari, Giovanni; Montalto, Claudio; Shumkova, Monika; de Oliveira, Elayne Kelen; Angeli, Francesco; Orzalkiewicz, Mateusz; Fabroni, Margherita; Baydaroglu, Nurcan; Munafò, Andrea Raffaele; D'Atri, Daniele Oreste; Casenghi, Matteo; Scisciola, Lucia; Barbieri, Michelangela; Marfella, Raffaele; Gragnano, Felice; Conte, Edoardo; Pellegrini, Dario; Ielasi, Alfonso; Andreini, Daniele; Penicka, Martin; Oreglia, Jacopo Andrea; Calabrò, Paolo; Bartorelli, Antonio; Pizzi, Carmine; Palmerini, Tullio; Vanderheyden, Marc; Saia, Francesco; Ribichini, Flavio; Barbato, Emanuele, Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) «CARDIOVASCULAR DIABETOLOGY» , vol. 24 , n. 12025pp. 1-14

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share